US2006008855A1PendingUtilityA1
Promiscuous G-protein compositions and their use
Assignee: INVITROGEN CORP A DELAWARE CORPriority: Jun 21, 1996Filed: Sep 16, 2005Published: Jan 12, 2006
Est. expiryJun 21, 2016(expired)· nominal 20-yr term from priority
G01N 33/5008C07K 14/705C12N 15/85C12N 2830/002C12N 2830/003G01N 33/5041
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Disclosed are compositions and methods for their use, such as in identifying G-protein coupled receptors and ligands and compounds that modulate signal transduction. The compositions and methods employ promicuous G-proteins. Activation of the promiscous G-protein can be detected in a variety of assays, including assays in which activation is indicated by a change in fluorescence emission of a sample that contains the composition.
Claims
exact text as granted — not AI-modified1 . A stable, isolated cell comprising a construct comprising promoter operably linked to a polynucleotide encoding a polypeptide having a biological activity of a promiscuous Gα protein.
2 . The cell of claim 1 , wherein said promoter is an inducible promoter.
3 . The cell of claim 2 , wherein said construct permits expression in a mammalian cell.
4 . The cell of claim 1 , wherein said polynucleotide has a nucleotide sequence with at least 70% sequence identity to a nucleotide sequence selected from the group consisting of the nucleotide sequence of Gα 16 (SEQ ID NO: 1), and the nucleotide sequence of Gα 15 (SEQ ID NO: 2).
5 .- 7 . (canceled)
8 . The cell of claim 1 , further comprising a second construct comprising a reporter gene operably linked to a second promoter, wherein said second promoter is modulated by a promiscuous Gα protein.
9 . The cell of claim 8 , wherein the reporter gene encodes a reporter selected from the group consisting of luciferase, green fluorescent protein, chloramphenicol acetyl transferase, β-galactosidase, alkaline phosphatase, β-lactamase, and human growth hormone.
10 .- 11 . (canceled)
12 . The cell of claim 8 , wherein the reporter gene encodes β-lactamase.
13 . The cell of claim 8 , wherein said second promoter comprises a protein kinase C-responsive promoter.
14 .- 26 . (canceled)
27 . A method of identifying a GPCR for a given ligand, the method comprising:
(i) expressing a putative GPCR in a cell of claim 1; (ii) contacting said cell with a ligand; and (iii) detecting reporter gene expression.
28 . The method of claim 27 , wherein said detecting comprises fluorescence detection.
29 . The method of claim 28 , further comprising contacting said cell with a reporter gene substrate.
30 . The method of claim 27 , further comprising contacting said cell with a compound that increases calcium levels inside said cell.
31 . The method of claim 30 , wherein said compound is selected from the group consisting of ionomycin and thapsigargin.
32 . The method of claim 30 , further comprising contacting said cell with phorbol myristate acetate or an analog thereof.
33 . A method of a identifying of a ligand for a given GPCR, the method comprising:
a) expressing a GPCR in a cell of claim 1; b) contacting said cell with a test chemical; and c) detecting a signal with a signal transduction detection system.
34 .- 36 . (canceled)
37 . The method of claim 33 , wherein said detecting comprises reporter gene detection.
38 . A method for identifying a modulator of signal transduction in a cell, the method comprising:
a) contacting a cell of claim 1 with a test chemical; b) contacting said cell with a ligand that, in the absence of the test chemical, activates signal transduction in said cell, and c) detecting a signal with a signal transduction detection system.
39 .- 42 . (canceled)
43 . A kit comprising assay reagents and a container containing a cell of claim 1 .
44 .- 62 . (canceled)Join the waitlist — get patent alerts
Track US2006008855A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.